Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors

被引:37
作者
Wang, Zhen [1 ,2 ]
Zhang, Yali [3 ]
Bartual, Sergio G. [5 ]
Luo, Jinfeng [2 ]
Xu, Tingting [4 ]
Du, Wenting [6 ,7 ]
Xun, Qiuju [2 ]
Tu, Zhengchao [2 ]
Brekken, Rolf A. [6 ,7 ]
Ren, Xiaomei [2 ]
Bullock, Alex N. [5 ]
Liang, Guang [3 ]
Lu, Xiaoyun [1 ]
Ding, Ke [1 ]
机构
[1] Jinan Univ, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China
[2] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China
[3] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pulm Med, Wenzhou, Peoples R China
[5] Univ Oxford, Struct Genom Consortium, Old Rd Campus,Roosevelt Dr, Oxford OX3 7DQ, England
[6] UT Southwestern Med Ctr, Div Surg Oncol, Dept Surg, Dallas, TX 75390 USA
[7] UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
基金
中国国家自然科学基金; 巴西圣保罗研究基金会; 英国惠康基金; 加拿大创新基金会;
关键词
DDR1; inhibitor; structure-activity relationship (SAR); inflammation; acute lung injury (ALI); KINASE INHIBITORS; TYROSINE KINASES; COLLAGEN; DISCOVERY; IDENTIFICATION; DISEASE; BINDING; POTENT; MICE;
D O I
10.1021/acsmedchemlett.6b00497
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Acute lung injury (ALI) is a deadly symptom for serious lung inflammation. Discoidin Domain Receptor 1 (DDR1) is a new potential target for anti-inflammatory drug discovery. A new selective tetrahydroisoquinoline-7-carboxamide based DDR1 inhibitor 7ae was discovered to tightly bind the DDR1 protein and potently inhibit its kinase function with a K-d value of 2.2 nM and an IC50 value of 6.6 nM, respectively. The compound dose-dependently inhibited lipopolysaccharide (LPS)-induced interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) release in mouse primary peritoneal macrophages (MPMs). In addition, 7ae also exhibited promising in vivo anti-inflammatory effects in a LPS-induced mouse ALI model. To the best of our knowledge, this is the first "proof of concept" investigation on the potential application of a small molecule DDR1 inhibitor to treat ALI.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 28 条
[1]   Interaction of discoidin domain receptor 1 with collagen type 1 [J].
Agarwal, Gunjan ;
Mihai, Cosmin ;
Iscru, Daniel F. .
JOURNAL OF MOLECULAR BIOLOGY, 2007, 367 (02) :443-455
[2]  
ALVES F, 1995, ONCOGENE, V10, P609
[3]   Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis [J].
Avivi-Green, Carmel ;
Singal, Mayank ;
Vogel, Wolfgang F. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (04) :420-427
[4]   Discoidin domain receptors in disease [J].
Borza, Corina M. ;
Pozzi, Arnbra .
MATRIX BIOLOGY, 2014, 34 :185-192
[5]   Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury [J].
Chen, Gaozhi ;
Zhang, Yali ;
Liu, Xing ;
Fang, Qilu ;
Wang, Zhe ;
Fu, Lili ;
Liu, Zhiguo ;
Wang, Yi ;
Zhao, Yunjie ;
Li, Xiaokun ;
Liang, Guang .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (06) :2436-2451
[6]   Discovery of a broad spectrum antiproliferative agent with selectivity for DDR1 kinase: cell line-based assay, kinase panel, molecular docking, and toxicity studies [J].
Elkamhawy, Ahmed ;
Park, Jung-eun ;
Cho, Nam-Chul ;
Sim, Taebo ;
Pae, Ae Nim ;
Roh, Eun Joo .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (01) :158-166
[7]   A small molecule-kinase interaction map for clinical kinase inhibitors [J].
Fabian, MA ;
Biggs, WH ;
Treiber, DK ;
Atteridge, CE ;
Azimioara, MD ;
Benedetti, MG ;
Carter, TA ;
Ciceri, P ;
Edeen, PT ;
Floyd, M ;
Ford, JM ;
Galvin, M ;
Gerlach, JL ;
Grotzfeld, RM ;
Herrgard, S ;
Insko, DE ;
Insko, MA ;
Lai, AG ;
Lélias, JM ;
Mehta, SA ;
Milanov, ZV ;
Velasco, AM ;
Wodicka, LM ;
Patel, HK ;
Zarrinkar, PP ;
Lockhart, DJ .
NATURE BIOTECHNOLOGY, 2005, 23 (03) :329-336
[8]   Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease [J].
Flamant, Martin ;
Placier, Sandrine ;
Rodenas, Anita ;
Curat, Cyrile Anne ;
Vogel, Wolfgang F. ;
Chatziantoniou, Christos ;
Dussaule, Jean-Claude .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (12) :3374-3381
[9]   Discovery and Optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)-ethynyl)benzamides as Novel Selective and Orally Bioavailable Discoidin Domain Receptor 1 (DDR1) Inhibitors [J].
Gao, Mingshan ;
Duan, Lei ;
Luo, Jinfeng ;
Zhang, Lianwen ;
Lu, Xiaoyun ;
Zhang, Yan ;
Zhang, Zhang ;
Tu, Zhengchao ;
Xu, Yong ;
Ren, Xiaomei ;
Ding, Ke .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (08) :3281-3295
[10]   Discoidin domain receptors: a proteomic portrait [J].
Iwai, Leo K. ;
Luczynski, Maciej T. ;
Huang, Paul H. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (17) :3269-3279